UTIs

R&D

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

News

Rapid urine tests could help NHS ensure that antibiotics are used appropriately.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.